<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T07:36:25Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10459.1/57176" metadataPrefix="marc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10459.1/57176</identifier><datestamp>2024-12-05T22:36:29Z</datestamp><setSpec>com_2072_3622</setSpec><setSpec>col_2072_479130</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
   <leader>00925njm 22002777a 4500</leader>
   <datafield ind2=" " ind1=" " tag="042">
      <subfield code="a">dc</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Parisi Capdevila, Eva</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Bozic, Milica</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Ibarz Escuer, Mercedes</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Panizo García, Sara</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Valcheva, Petya</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Coll, Blai</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Fernández i Giráldez, Elvira</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Valdivielso Revilla, José Manuel</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="260">
      <subfield code="c">2016-06-09T08:29:39Z</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="260">
      <subfield code="c">2025-01-01</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="260">
      <subfield code="c">2010</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="520">
      <subfield code="a">N-methyl-D-aspartate&#xd;
(NMDA) receptors (NMDAR) are tetrameric amino acid receptors&#xd;
that act as membrane calcium channels. The presence of the receptor&#xd;
has been detected in the principal organs responsible for calcium&#xd;
homeostasis (kidney, bone, and parathyroid gland), pointing to a&#xd;
possible role in mineral metabolism. The aim of this study was to test&#xd;
the effect of NMDAR activation in the kidney and on 1,25(OH)2D3&#xd;
synthesis. We determined the presence of NMDAR subunits in HK-2&#xd;
(human kidney cells) cells and proved its functionality. NMDA&#xd;
treatment for 4 days induced a decrease in 1 -hydroxylase levels and&#xd;
1,25(OH)2D3 synthesis through the activation of the MAPK/ERK&#xd;
pathway in HK-2 cells. In vivo administration of NMDA for 4 days&#xd;
also caused a decrease in blood 1,25(OH)2D3 levels in healthy animals&#xd;
and an increase in blood PTH levels. This increase in PTH induced a&#xd;
decrease in the urinary excretion of calcium and an increase in urinary&#xd;
excretion of phosphorous and sodium as well as in diuresis. Bone&#xd;
turnover markers also increased. Animals with 5/6 nephrectomy&#xd;
showed low levels of renal 1 -hydroxylase as well as high levels of&#xd;
renal glutamate compared with healthy animals. In conclusion,&#xd;
NMDAR activation in the kidney causes a decrease in 1,25(OH)2D3&#xd;
synthesis, which induces an increase on PTH synthesis and release. In&#xd;
animals with chronic kidney disease, high renal levels of glutamate&#xd;
could be involved in the downregulation of 1 -hydroxylase expression.</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="520">
      <subfield code="a">This work was supported by FIS PI09/0299, FIS PI07/0427, and REDINREN&#xd;
(16/06).</subfield>
   </datafield>
   <datafield ind1="8" ind2=" " tag="024">
      <subfield code="a">http://hdl.handle.net/10459.1/57176</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Paratyroid hormone</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Mitogen- activated protein kinase</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Hyerparatyroidism</subfield>
   </datafield>
   <datafield ind2="0" ind1="0" tag="245">
      <subfield code="a">Sustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPT</subfield>
   </datafield>
</record></metadata></record></GetRecord></OAI-PMH>